← FDA Drug Approvals (Drugs@FDA)

ICATIBANT ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NANG KUANG PHARM CO · Approved 2020-12-16

Drug application

FDA Application #
ANDA212081
Application type
Abbreviated New Drug Application (Generic)
Brand name
ICATIBANT ACETATE
Generic name
Icatibant Acetate
Active ingredients
ICATIBANT ACETATE
Dosage form
INJECTABLE
Route
SUBCUTANEOUS
Marketing status
Prescription
Sponsor
NANG KUANG PHARM CO
First approval
2020-12-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown